These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24751702)
21. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy. Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825 [TBL] [Abstract][Full Text] [Related]
22. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma. Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785 [TBL] [Abstract][Full Text] [Related]
23. Radioactive iodine and the salivary glands. Mandel SJ; Mandel L Thyroid; 2003 Mar; 13(3):265-71. PubMed ID: 12729475 [TBL] [Abstract][Full Text] [Related]
24. Gonadal damage due to radioactive iodine (I131) treatment for thyroid carcinoma. Ahmed SR; Shalet SM Postgrad Med J; 1985 Apr; 61(714):361-2. PubMed ID: 4022871 [TBL] [Abstract][Full Text] [Related]
25. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176 [TBL] [Abstract][Full Text] [Related]
26. Radioactive iodine treatment for differentiated thyroid carcinoma in Japan. Okamoto T Surgery; 2010 Mar; 147(3):432-3. PubMed ID: 20176244 [No Abstract] [Full Text] [Related]
27. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution. Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082 [TBL] [Abstract][Full Text] [Related]
28. Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer. Fard-Esfahani A; Farzanefar S; Fallahi B; Beiki D; Saghari M; Emami-Ardekani A; Majdi M; Eftekhari M Nucl Med Commun; 2012 Oct; 33(10):1077-80. PubMed ID: 22825036 [TBL] [Abstract][Full Text] [Related]
29. Improving postoperative recurrence rates for carcinoma of the thyroid gland. McHenry C; Jarosz H; Lawrence AM; Paloyan E Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754 [TBL] [Abstract][Full Text] [Related]
30. Radioiodine ablation: when and how. Ambrosetti MC; Colato C; Dardano A; Monzani F; Ferdeghini M Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):473-81. PubMed ID: 19910900 [TBL] [Abstract][Full Text] [Related]
31. Iodide mumps: a case report of complicated radioactive iodine causing sialadenitis. Lei L; Velasco O; Nobay F Am J Emerg Med; 2012 Mar; 30(3):512.e5-6. PubMed ID: 21354757 [TBL] [Abstract][Full Text] [Related]
32. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer. Lassmann M; Luster M; Hänscheid H; Reiners C J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368 [No Abstract] [Full Text] [Related]
33. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131. Sfakianakis G; Sfakianaki E Hell J Nucl Med; 2007; 10(1):2-5. PubMed ID: 17450241 [TBL] [Abstract][Full Text] [Related]
34. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer. Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145 [TBL] [Abstract][Full Text] [Related]
35. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. Kloos RT; Duvuuri V; Jhiang SM; Cahill KV; Foster JA; Burns JA J Clin Endocrinol Metab; 2002 Dec; 87(12):5817-20. PubMed ID: 12466391 [TBL] [Abstract][Full Text] [Related]